Iterum Therapeutics plc
Iterum Therapeutics plc (ITRM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ITRM · as of Jun 9, 2026
Key Statistics
Explore Iterum Therapeutics plc Data
itrm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
itrm competitorsITRM
ANTX
BOLD
IBIO
INTS
KLTOStock Performance
Full HistoryAbout Iterum Therapeutics plc
Iterum Therapeutics plc is a clinical-stage biopharmaceutical firm dedicated to the development and commercialization of anti-infective treatments. The company operates across Ireland, Bermuda, and th…
what is iterum therapeutics plc · itrm stock overview · iterum therapeutics plc company profile · who is iterum therapeutics plc ceo · itrm NASDAQ · iterum therapeutics plc headquarters · iterum therapeutics plc business segments
About Stock Overview & Key Data
Iterum Therapeutics plc (ITRM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 25, 2018. As of the latest trading session, ITRM stock price is $0.03, with a market capitalization of $1.6M. The stock has returned -97.32% over the past 12 months and -91.04% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Iterum Therapeutics plc stock is Hold, with an average 12-month price target of $—. In fiscal year 2024, Iterum Therapeutics plc reported revenue of — and net income of -$24.8M. For detailed data — including Iterum Therapeutics plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Iterum Therapeutics plc (ITRM) stock price is $0.03. The stock is traded on NASDAQ under the ticker symbol ITRM. The 52-week range is $0.03 – $1.42.